Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 47.68% | -6.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.29% | -0.82% | |||
| Operating Income | -15.29% | 0.82% | |||
| Income Before Tax | -14.43% | 5.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.58% | 5.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.58% | 5.62% | |||
| EBIT | -15.29% | 0.82% | |||
| EBITDA | -15.43% | 1.19% | |||
| EPS Basic | 0.55% | 31.43% | |||
| Normalized Basic EPS | 0.70% | 31.34% | |||
| EPS Diluted | 0.55% | 31.43% | |||
| Normalized Diluted EPS | 0.70% | 31.34% | |||
| Average Basic Shares Outstanding | 15.18% | 37.65% | |||
| Average Diluted Shares Outstanding | 15.18% | 37.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||